Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Durlin E. Hickok is active.

Publication


Featured researches published by Durlin E. Hickok.


The New England Journal of Medicine | 1991

CESAREAN SECTION BEFORE THE ONSET OF LABOR AND SUBSEQUENT MOTOR FUNCTION IN INFANTS WITH MENINGOMYELOCELE DIAGNOSED ANTENATALLY

David A. Luthy; Terrence Wardinsky; David B. Shurtleff; Kathryn A. Hollenbach; Durlin E. Hickok; David A. Nyberg; Thomas J. Benedetti

Methods. To assess the effect of labor and type of delivery on the level of motor function in fetuses with uncomplicated meningomyelocele, we identified 200 cases of this disorder, accounting for 95 percent of the cases that occurred in the state of Washington during our 10-year study period. We compared the outcomes of 47 infants delivered by cesarean section before labor began, 35 delivered by cesarean section after a period of labor, and 78 who were delivered vaginally (another 40 were ineligible for the study)


American Journal of Obstetrics and Gynecology | 1992

The frequency of breech presentation by gestational age at birth: A large population-based study

Durlin E. Hickok; Diane Gordon; John Milberg; Michelle A. Williams; Janet R. Daling

From a study of birth records, breech presentation at delivery for each gestational age was found to be less frequent as compared with other reports about antenatal ultrasonographic examination. Selection bias or the effect of labor may account for the observed difference.


American Journal of Obstetrics and Gynecology | 2014

Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes

C. Andrew Combs; Michael Gravett; Thomas J. Garite; Durlin E. Hickok; Jodi Lapidus; Richard P. Porreco; Julie Rael; Thomas Grove; Terry K. Morgan; William Clewell; Hugh Miller; David A. Luthy; Leonardo Pereira; Michael P. Nageotte; Peter Robilio; Stephen J. Fortunato; Hyagriv N. Simhan; Jason K. Baxter; Erol Amon; Albert Franco; Kenneth Trofatter; Kent Heyborne

OBJECTIVE The purpose of this study was to compare intraamniotic inflammation vs microbial invasion of the amniotic cavity (MIAC) as predictors of adverse outcome in preterm labor with intact membranes. STUDY DESIGN Interleukin-6 (IL-6) was measured in prospectively collected amniotic fluid from 305 women with preterm labor. MIAC was defined by amniotic fluid culture and/or detection of microbial 16S ribosomal DNA. Cases were categorized into 5 groups: infection (MIAC; IL-6, ≥11.3 ng/mL); severe inflammation (no MIAC; IL-6, ≥11.3 ng/mL); mild inflammation (no MIAC; IL-6, 2.6-11.2 ng/mL); colonization (MIAC; IL-6, <2.6 ng/mL); negative (no MIAC; IL-6, <2.6 ng/mL). RESULTS The infection (n = 27) and severe inflammation (n = 36) groups had similar latency (median, <1 day and 2 days, respectively) and similar rates of composite perinatal morbidity and mortality (81% and 72%, respectively). The colonization (n = 4) and negative (n = 195) groups had similar outcomes (median latency, 23.5 and 25 days; composite morbidity and mortality rates, 21% and 25%, respectively). The mild inflammation (n = 47) groups had outcomes that were intermediate to the severe inflammation and negative groups (median latency, 7 days; composite morbidity and mortality rates, 53%). In logistic regression adjusting for gestational age at enrollment, IL-6 ≥11.3 and 2.6-11.2 ng/mL, but not MIAC, were associated significantly with composite morbidity and mortality rates (odds ratio [OR], 4.9; 95% confidence interval [CI], 2.2-11.2, OR, 3.1; 95% CI, 1.5-6.4, and OR, 1.8; 95% CI, 0.6-5.5, respectively). CONCLUSION We confirmed previous reports that intraamniotic inflammation is associated with adverse perinatal outcomes whether or not intraamniotic microbes are detected. Colonization without inflammation appears relatively benign. Intraamniotic inflammation is not simply present or absent but also has degrees of severity that correlate with adverse outcomes. We propose the designation amniotic inflammatory response syndrome to denote the adverse outcomes that are associated with intraamniotic inflammation.


Epidemiology | 1995

Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies.

De Kun Li; Janet R. Daling; Beth A. Mueller; Durlin E. Hickok; Alan G. Fantel; Noel S. Weiss

To study the relation of maternal periconceptional vitamin use to the risk of a congenital urinary tract anomaly (CUTA), we conducted a case-control study using the Washington State Birth Defect Registry. We identified CUTA cases with no known chromosomal abnormality in seven counties in western Washington State occurring between January 1, 1990, and December 31, 1991. We randomly selected a sample, as controls, of all infants delivered in five large hospitals in King County who did not have a birth defect and who were born in the same year as the cases. About 55% of all infants in King County and a smaller proportion of infants in the other six counties are delivered in these five hospitals. We interviewed mothers of 118 cases and 369 controls to obtain information about their vitamin use during the pregnancy and during the year before the conception. After adjustment for maternal race, family income, county of maternal residence, and birth year, we found that women who used multivitamins during the first trimester had only 15% the risk of bearing a child with a CUTA compared with women who did not take vitamins [odds ratio (OR) = 0.15; 95% confidence interval (CI) = 0.05–0.43]. The reduction was smaller for use restricted to the second or third trimesters (OR = 0.31; 95% CI = 0.09–1.02). Among women who used vitamins during the first trimester, vitamin use before conception was not associated with any further reduction in the risk, nor did there appear to be an association with the amount or brand of vitamin used. Restricting the analysis to residents of King County did not change the results. Our results indicate that prenatal multivitamin use, particularly during the first trimester, may reduce the risk of a CUTA. Because all of the preparations taken by study participants contained many vitamins as well as folic acid, it was not possible to identify which one (or several) chemical(s) may have been responsible for the reduced risk of a CUTA.


Obstetrics & Gynecology | 1995

Risk factors for preeclampsia in twin pregnancies: a population-based cohort study.

Dean Coonrod; Durlin E. Hickok; Kangmin Zhu; Thomas R. Easterling; Janet R. Daling

Objective To evaluate in twin pregnancies the characteristics parity, race, smoking, and age, known to be risk factors for preeclampsia in non-twin pregnancies. Methods All twin pregnancies (3407) and approximately twice as many singletons (8287) were assembled using Washington state birth certificates from the period 1984–1988. Results In singleton pregnancies, preeclampsia was more common in women who were younger, black, poor, nulliparous, and nonsmokers. In twin pregnancies, similar associations were found, but were only statistically significant for age, race, and parity. There were no significant differences in the risk factors between twin and singleton women. Logistic regression showed that twin pregnancy carries a relative risk (RR) of 3.5 (95% confidence interval [CI] 3.0–4.2), nulliparity an RR of 4.0 (95% CI 3.3–4.8), and black race an RR of 1.8 (95% CI 1.2–2.6) for preeclampsia. In each case, this risk is independent of the other risk factors. Conclusion Twin pregnancy carries nearly a fourfold increased risk of preeclampsia, independent of race and parity, and the risk of a nulliparous twin pregnancy is 14 times that of a parous singleton pregnancy. Risk factors in a singleton pregnancy act similarly in a twin pregnancy. Thus, any pathophysiologic model for preeclampsia needs to account for the risk twin pregnancy poses as well as other risk factors, such as parity and race.


American Journal of Obstetrics and Gynecology | 1993

Humerus and femur length shortening in the detection of Down's syndrome

David A. Nyberg; Robert G. Resta; David A. Luthy; Durlin E. Hickok; Michelle A. Williams

OBJECTIVE Our purpose was to determine the utility of screening for humerus and femur length shortening in prenatal detection of Downs syndrome (trisomy 21). STUDY DESIGN On the basis of the biparietal diameter, predicted humerus and femur lengths were derived from a sample control group of 350 karyotypically normal fetuses. The regression formulas were prospectively applied to 45 consecutive fetuses with Downs syndrome and 942 fetuses with normal karyotypes. Ratios of measured humerus length/predicted humerus length and measured femur length/predicted femur length were calculated for each fetus. RESULTS Eleven of 45 (24.4%) fetuses with Downs syndrome had short humerus (measured humerus length/predicted humerus length ratio of < or = 0.89), and 11 (24.4%) had short femur (measured femur length/predicted femur length ratio of < or = 0.91. In comparison, among 942 karyotypically normal fetuses only 43 (4.5%) showed short humerus and 44 (4.7%) showed short femur (p < 0.05). Fetuses with both short humerus and short femur carried an 11-fold greater risk of Downs syndrome (risk ratio = 11.1; 95% confidence interval = 5.0 to 25.0). CONCLUSION Prenatal ultrasonographic detection of short humerus to short femur, or both significantly increase the risk of Downs syndrome; this information may be useful in screening programs.


American Journal of Obstetrics and Gynecology | 1990

The “stuck twin” phenomenon: Ultrasonographic findings, pregnancy outcome, and management with serial amniocenteses

B S Mahony; C N Petty; David A. Nyberg; David A. Luthy; Durlin E. Hickok; J Hirsch

Abstract Thirteen consecutive twin pregnancies affected by the “stuck twin” phenomenon were reviewed to determine the potential benefit of serial amniocenteses. The fetal survival rate for the eight pregnancies that underwent serial amniocenteses was 69% (11 of 16 fetuses). This is significantly improved compared with a fetal survival rate of 20% among the five preceding pregnancies managed without serial amniocenteses at the same institution (p = 0.01). It is also markedly improved compared with a combined fetal survival rate of 16% among 48 previously reported pregnancies with the stuck twin phenomenon managed without serial amniocenteses (p


Journal of Ultrasound in Medicine | 1993

Prenatal sonographic findings of trisomy 18: review of 47 cases.

David A. Nyberg; D Kramer; Robert G. Resta; Raj P. Kapur; B S Mahony; David A. Luthy; Durlin E. Hickok

Prenatal sonographic findings were reviewed in 47 consecutive fetuses with trisomy 18. One or more abnormalities, excluding choroid plexus cysts, were found in 39 fetuses (83%), including 21 of 29 (72%) fetuses examined between 14 and 24 weeks and all 18 (100%) fetuses examined after 24 weeks. Abnormalities most frequently detected before 24 weeks included cystic hygromas, nuchal thickening, and meningomyelocele. Intrauterine growth retardation, cardiac defects, and an enlarged cisterna magna were detected more frequently after 24 weeks than before 24 weeks (P < 0.05). Intrauterine growth retardation was the single most common abnormality, detected in 51% of all fetuses and 89% of fetuses examined after 24 weeks. Choroid plexus cysts were identified in 25% (12 of 47) of fetuses, including 11 of 29 (38%) fetuses seen before 24 weeks. Additional abnormalities were identified in 10 of 12 (83%) fetuses with choroid plexus cysts; one of the two remaining fetuses showed clenched hands and a cardiac anomaly at autopsy, and the other showed unusually large, multiple choroid plexus cysts. Awareness of the type of anomalies and the usual menstrual age of diagnosis in fetuses with trisomy 18 should improve patient counseling and prenatal detection of fetuses considered at risk for this disorder.


American Journal of Obstetrics and Gynecology | 1993

Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension

Tanya K. Sorensen; Michelle A. Williams; Rosalee W. Zingheim; Susan J. Clement; Durlin E. Hickok

OBJECTIVE Pregnancy-induced hypertension is believed to be a disorder of the vascular endothelium, possibly focused in the placenta. Markers such as cellular fibronectin appear early in patients in whom pregnancy-induced hypertension develops. We hypothesized that patients with elevated second-trimester levels of human chorionic gonadotropin would have an increased risk for pregnancy-induced hypertension. STUDY DESIGN We conducted a cohort study, using a database of patients undergoing second-trimester serum screening for Down syndrome and who were delivered at our institution between January 1990 and August 1991. We included all 180 women with human chorionic gonadotropin levels > or = 2.0 multiples of the median. A sequential sample of 369 women with levels < 2.0 multiples of the median served as the referent group. Standard American College of Obstetricians and Gynecologists definitions of pregnancy-induced hypertension and proteinuria were used. RESULTS Patients with elevated human chorionic gonadotropin levels were at increased risk for pregnancy-induced hypertension (risk ratio 1.7, 95% confidence interval 1.2 to 2.4) and proteinuric pregnancy-induced hypertension (risk ratio 5.1, 95% confidence interval 1.6 to 16.2). Adjusting for potential confounding factors did not alter these associations. CONCLUSIONS Patients with elevated human chorionic gonadotropin appear to be at higher risk of pregnancy-induced hypertension and proteinuric pregnancy-induced hypertension. Second-trimester human chorionic gonadotropin levels should be further investigated as a potential marker for pregnancy-induced hypertension.


American Journal of Obstetrics and Gynecology | 1982

Recurrent genital herpes simplex virus infection in pregnancy: Infant outcome and frequency of asymptomatic recurrences☆☆☆

Louis A. Vontver; Durlin E. Hickok; Zane A. Brown; Lucy Reid; Lawrence Corey

Eighty pregnant patients with a history of recurrent genital herpes simplex virus (HSV) infection were followed up with frequent genital examinations and cultures for HSV during their pregnancies. Recurrences of genital HSV during pregnancy were documented in 67 patients. Ninety-six percent of these had external genital lesions noted at some time during their pregnancy. One hundred eighty-six (93%) of the 199 recurrences of the disease were associated with external genital lesions. Of 13 episodes of asymptomatic viral shedding documented in this patient population, six were from the vulva alone, five were from the cervix alone, and two were from both the vulva and the cervix. Of 11 episodes of cervical HSV shedding, seven were asymptomatic and four were associated with external symptomatic lesions. Despite frequent recurrences of genital HSV infection during pregnancy, all study patients were delivered at term, and although they had a high rate of delivery by cesarean section (32.5%), the outcome of their infants was good.

Collaboration


Dive into the Durlin E. Hickok's collaboration.

Top Co-Authors

Avatar

David A. Luthy

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Scott Sullivan

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Janet R. Daling

Fred Hutchinson Cancer Research Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge